Mr. Jose Luis Lopez-lopez, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Ave Los Patriotas Km 1.8, Ziena Professional Plaza Suite #7, Lares, PR 00669 Phone: 787-897-8106 |
Dr. Carlos Francisco Planell Dosal, M.D Dentist - General Practice Medicare: Accepting Medicare Assignments Practice Location: Street 111 Km 23.6, Bo. Lares, Lares, PR 00669 Phone: 787-897-3752 |
Dr. Luis Alberto Grana Santiago, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 22 Calle Pedro Albizu Campos, Lares, PR 00669 Phone: 787-897-1810 Fax: 787-897-1810 |
Dr. Juan Rosado Valentin, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: Urb Buena Vista 17, Calle Ramon De Jesus Sierra, Lares, PR 00669 Phone: 787-897-2080 Fax: 787-897-7736 |
Dr. Ricardo Alejandro Lopez Perez, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 111 Ave Los Patriotas Km 33.2 Ziema Professional Plaza, Suite #7, Lares, PR 00669 Phone: 787-897-8106 |
News Archive
The federal agency that oversees a large network of research centers seeking cures for hundreds of rare, disabling and often fatal diseases has named Cincinnati Children's as its new data management and coordinating center.
BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrendsĀ®: Gout and Hyperuricemia publication. The report is based on responses to online surveys completed by 120 Rheumatologists and 57 Primary Care Physicians in the US who are managing a high number of patients with gout.
Apps that test visual function at home can discover deterioration of the eye's macula lutea long before traditional vision tests. A doctoral thesis at Sahlgrenska Academy explored this issue.
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. "The presentations this year are very significant for clinicians, and outline real progress in the development of agents that are effective in managing and treating gastrointestinal diseases," says Eric Van Cutsem, MD, PhD of the University Hospital Gasthuisberg in Leuven, Belgium and Congress co-chair.
Accumetrics, Inc., developer and marketer of the VerifyNow System, today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety) Trial found that in patients with high residual platelet reactivity, doubling the maintenance dose of clopidogrel did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).
› Verified 5 days ago